Thieme E-Books & E-Journals -
Neuropediatrics, Table of Contents
Neuropediatrics 2018; 49(S 02): S1-S69
DOI: 10.1055/s-0038-1675896
Oral Presentation
Movement Disorders II
Georg Thieme Verlag KG Stuttgart · New York

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Authors

  • Nikolas Boy

    1   Division of Child Neurology and Metabolic Medicine, University Hospital Heidelberg, Heidelberg, Germany

  • Katharina Mengler

    1   Division of Child Neurology and Metabolic Medicine, University Hospital Heidelberg, Heidelberg, Germany

  • Eva Thimm

    2   Division of Experimental Paediatrics and Metabolism, Department of General Paediatrics, Neonatology and Paediatric Cardiology, University Children’s Hospital, Heinrich Heine University Düsseldorf, Düsseldorf, Germany

  • Katharina A. Schiergens

    3   Dr. von Hauner Children’s Hospital, Ludwig-Maximilians-University, Munich, Munich, Germany

  • Thorsten Marquardt

    4   Department of General Paediatrics, Metabolic Diseases, University Children’s Hospital Muenster, Muenster, Germany

  • Natalie Weinhold

    5   Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Center for Chronically Sick Children, Berlin, Germany

  • Iris Marquardt

    6   Department of Child Neurology, Children’s Hospital Oldenburg, Oldenburg, Germany

  • Anibh M. Das

    7   Department of Paediatrics, Paediatric Metabolic Medicine, Hannover Medical School, Hannover, Germany

  • Peter Freisinger

    8   Children’s Hospital Reutlingen, Reutlingen, Germany

  • Sarah C. Grünert

    9   Department of General Paediatrics, Adolescent Medicine and Neonatology, Faculty of Medicine, University of Freiburg, Freiburg, Germany

  • Judith Vossbeck

    10   Department of Paediatric and Adolescent Medicine, Ulm University Medical School, Ulm, Germany

  • Robert Steinfeld

    11   Department of Paediatrics and Paediatric Neurology, University Medical Center, Göttingen, Germany

  • Matthias R. Baumgartner

    12   Division of Metabolism and Children’s Research Centre, University Children’s Hospital Zurich, Zurich, Switzerland

  • Skadi Beblo

    13   Department of Women and Child Health, Centre for Paediatric Research Leipzig (CPL), Hospital for Children and Adolescents, University Hospitals, University of Leipzig, Lepzig, Germany

  • Andrea Dieckmann

    14   Department of Neuropediatrics, Centre for Inborn Metabolic Disorders, Jena University Hospital, Jena, Germany

  • Andrea Näke

    15   Children’s Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany

  • Martin Lindner

    16   Division of Paediatric Neurology, University Children’s Hospital Frankfurt, Frankfurt, Germany

  • Jana Heringer

    1   Division of Child Neurology and Metabolic Medicine, University Hospital Heidelberg, Heidelberg, Germany

  • Georg F. Hoffmann

    1   Division of Child Neurology and Metabolic Medicine, University Hospital Heidelberg, Heidelberg, Germany

  • Chris Mühlhausen

    17   University Medical Centre Hamburg-Eppendorf, University Children’s Hospital, Hamburg, Germany

  • Esther M. Maier

    3   Dr. von Hauner Children’s Hospital, Ludwig-Maximilians-University, Munich, Munich, Germany

  • Regina Ensenauer

    2   Division of Experimental Paediatrics and Metabolism, Department of General Paediatrics, Neonatology and Paediatric Cardiology, University Children’s Hospital, Heinrich Heine University Düsseldorf, Düsseldorf, Germany

  • Sven F. Garbade

    1   Division of Child Neurology and Metabolic Medicine, University Hospital Heidelberg, Heidelberg, Germany

  • Stefan Kölker

    1   Division of Child Neurology and Metabolic Medicine, University Hospital Heidelberg, Heidelberg, Germany
eRefRecommend Article